Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals granted inducement equity awards to five new non-officer employees consisting of stock options and restricted share units. The grants include an aggregate of 13,450 share options and 7,850 RSUs, approved by the Compensation Committee under Nasdaq Listing Rule 5635(c)(4).
Key figures
- Rsus granted
- 7850
- New employees
- 5
- Exercise price
- 61.93
- Options granted
- 13450
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.